Company Filing History:
Years Active: 2021-2024
Title: Scott Pollard - Innovator in Depression Treatment
Introduction
Scott Pollard is a notable inventor residing in Cody, Wyoming, known for his contributions to the field of mental health treatment. With a total of three patents, Pollard has been actively working on innovative solutions aimed at addressing treatment-resistant depression, showcasing his commitment to improving patient outcomes.
Latest Patents
Among Pollard's latest patents is an innovative method for treating depression in patients who do not respond to traditional therapies. This patent outlines the administration of ketamine or dextromethorphan formulations via mucosal membranes. The method allows for effective absorption while bypassing the digestive tract, thus providing rapid-acting antidepressant effects. The invention includes specific routes of administration such as the respiratory tract, genitourinary tract, oral tract, or rectal tract. Additionally, the patent discusses a biomarker that can help identify depressive diseases, highlighting the clinical relevance of his work.
Career Highlights
Scott Pollard's professional journey is marked by his association with West Virginia University, where he has collaborated with leading professionals in the field. His relentless pursuit of innovative treatment methods has earned him recognition in the medical community, specifically for his research on mental health therapies.
Collaborations
In his work, Pollard has teamed up with notable colleagues including Patrick Marshalek and Rae Matsumoto. These collaborations are pivotal in the development of his patents, combining their expertise to advance treatment options for depression and enhance patient care strategies.
Conclusion
Scott Pollard's innovative solutions in the treatment of depression mark a significant step forward in addressing one of the most pressing mental health challenges today. Through his patents and collaborative efforts, he continues to contribute valuable insights to the field, aiming to improve the lives of individuals struggling with treatment-resistant depression.